- Filed
- Nov 13, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2026 · Nov 10, 2025 | 16.73M sh |
| Shares Diluted | Q2 2026 · Sep 30, 2025 | 16.7M sh |
| Shares Diluted | Q2 2026 · Sep 30, 2025 | 16.7M sh |
| Shares Diluted restated | Q2 2026 · Sep 30, 2024 | 16.7M sh |
| Shares Diluted restated | Q2 2026 · Sep 30, 2024 | 16.7M sh |
| Capex | Q2 2026 · Sep 30, 2025 | $12.1M |
| Capex restated | Q2 2026 · Sep 30, 2024 | $9.6M |
| Operating Cash Flow | Q2 2026 · Sep 30, 2025 | $39.3M |
| Operating Cash Flow restated | Q2 2026 · Sep 30, 2024 | −$24.4M |
| Long Term Debt | Q2 2026 · Sep 30, 2025 | $608.7M |
| Long Term Debt | Q2 2026 · Mar 31, 2025 | $699.9M |
| Short Term Debt | Q2 2026 · Sep 30, 2025 | $3.8M |
| Short Term Debt | Q2 2026 · Mar 31, 2025 | $0 |
| Cash And Equivalents | Q2 2026 · Sep 30, 2025 | $37M |
| Cash And Equivalents | Q2 2026 · Mar 31, 2025 | $17.8M |
| Stockholders Equity | Q2 2026 · Sep 30, 2025 | $663.2M |
| Stockholders Equity | Q2 2026 · Jun 30, 2025 | $712.3M |
| Stockholders Equity | Q2 2026 · Mar 31, 2025 | $766.4M |
| Stockholders Equity restated | Q2 2026 · Sep 30, 2024 | $935.9M |
| Stockholders Equity | Q2 2026 · Jun 30, 2024 | $973.1M |
| Stockholders Equity restated | Q2 2026 · Mar 31, 2024 | $919.2M |
| Current Liabilities | Q2 2026 · Sep 30, 2025 | $599.8M |
| Current Liabilities | Q2 2026 · Mar 31, 2025 | $622.5M |
| Total Liabilities | Q2 2026 · Sep 30, 2025 | $1.31B |
| Total Liabilities | Q2 2026 · Mar 31, 2025 | $1.41B |
| Current Assets | Q2 2026 · Sep 30, 2025 | $113.7M |
| Current Assets | Q2 2026 · Mar 31, 2025 | $170.5M |
| Total Assets | Q2 2026 · Sep 30, 2025 | $1.97B |
| Total Assets | Q2 2026 · Mar 31, 2025 | $2.17B |
| Eps Diluted | Q2 2026 · Sep 30, 2025 | −$3.15 |
| Eps Diluted | Q2 2026 · Sep 30, 2025 | −$5.69 |
| Eps Diluted restated | Q2 2026 · Sep 30, 2024 | −$1.83 |
| Eps Diluted restated | Q2 2026 · Sep 30, 2024 | −$1.57 |
| Eps Basic | Q2 2026 · Sep 30, 2025 | −$3.15 |
| Eps Basic | Q2 2026 · Sep 30, 2025 | −$5.69 |
| Eps Basic restated | Q2 2026 · Sep 30, 2024 | −$1.83 |
| Eps Basic restated | Q2 2026 · Sep 30, 2024 | −$1.57 |
| Sga Expense | Q2 2026 · Sep 30, 2025 | $28.8M |
| Sga Expense | Q2 2026 · Sep 30, 2025 | $57.9M |
| Sga Expense restated | Q2 2026 · Sep 30, 2024 | $26.3M |
| Sga Expense restated | Q2 2026 · Sep 30, 2024 | $52.9M |
| Net Income | Q2 2026 · Sep 30, 2025 | −$52.6M |
| Net Income | Q2 2026 · Sep 30, 2025 | −$35.2M |
| Net Income | Q2 2026 · Sep 30, 2025 | −$95.1M |
| Net Income | Q2 2026 · May 6, 2025 | −$7.3M |
| Net Income restated | Q2 2026 · Sep 30, 2024 | −$30.6M |
| Net Income restated | Q2 2026 · Sep 30, 2024 | −$26.4M |
| Net Income | Q2 2026 · Jun 30, 2024 | $4.2M |
| Operating Income | Q2 2026 · Sep 30, 2025 | −$34.8M |
| Operating Income | Q2 2026 · Sep 30, 2025 | −$61.7M |
| Operating Income restated | Q2 2026 · Sep 30, 2024 | −$17M |
| Operating Income restated | Q2 2026 · Sep 30, 2024 | −$6.9M |
| Revenue | Q2 2026 · Sep 30, 2025 | $320.9M |
| Revenue | Q2 2026 · Sep 30, 2025 | $640.6M |
| Revenue restated | Q2 2026 · Sep 30, 2024 | $346.9M |
| Revenue restated | Q2 2026 · Sep 30, 2024 | $694.5M |